Literature DB >> 22049046

Combining PCR with microscopy to reduce costs of laboratory diagnosis of Buruli ulcer.

Dorothy Yeboah-Manu1, Adwoa Asante-Poku, Kobina Asan-Ampah, Emelia Danso Edwin Ampadu, Gerd Pluschke.   

Abstract

The introduction of antibiotic therapy as first-line treatment of Buruli ulcer underlines the importance of laboratory confirmation of clinical diagnosis. Because smear microscopy has very limited sensitivity, the technically demanding and more expensive IS2404 diagnostic polymerase chain reaction (PCR) has become the main method for confirmation. By optimization of the release of mycobacteria from swab specimen and concentration of bacterial suspensions before smearing, we were able to improve the detection rate of acid-fast bacilli by microscopy after Ziehl-Neelsen staining. Compared with IS2404 PCR, which is the gold standard diagnostic method, the sensitivity and specificity of microscopy with 100 concentrated specimens were 58.4% and 95.7%, respectively. We subsequently evaluated a stepwise laboratory confirmation algorithm with detection of AFB as first-line method and IS2404 PCR performed only with those samples that were negative in microscopic analysis. This stepwise approach reduced unit cost by more than 50% to $5.41, and the total costs were reduced from $917 to $433.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22049046      PMCID: PMC3205638          DOI: 10.4269/ajtmh.2011.11-0362

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  17 in total

Review 1.  Buruli ulcer: emerging from obscurity.

Authors:  Mark Wansbrough-Jones; Richard Phillips
Journal:  Lancet       Date:  2006-06-03       Impact factor: 79.321

2.  Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans.

Authors:  S Etuaful; B Carbonnelle; J Grosset; S Lucas; C Horsfield; R Phillips; M Evans; D Ofori-Adjei; E Klustse; J Owusu-Boateng; G K Amedofu; P Awuah; E Ampadu; G Amofah; K Asiedu; M Wansbrough-Jones
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

Review 3.  Mycobacterium ulcerans infection.

Authors:  T S van der Werf; W T van der Graaf; J W Tappero; K Asiedu
Journal:  Lancet       Date:  1999-09-18       Impact factor: 79.321

4.  A controlled trial of the treatment of Mycobacterium ulcerans infection with clofazimine.

Authors:  W D Revill; R H Morrow; M C Pike; J Ateng
Journal:  Lancet       Date:  1973-10-20       Impact factor: 79.321

5.  Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler.

Authors:  M Semret; G Koromihis; J D MacLean; M Libman; B J Ward
Journal:  Am J Trop Med Hyg       Date:  1999-11       Impact factor: 2.345

6.  Ulcerative cutaneous mycobacteriosis due to Mycobacterium ulcerans: report of two Mexican cases.

Authors:  Josefa Novales-Santa Coloma; Gisela Navarrete-Franco; Pedro Iribe; Larissa Dorina López-Cepeda
Journal:  Int J Lepr Other Mycobact Dis       Date:  2005-03

7.  An outreach education and treatment project in Ghana for the early stage of Mycobacterium ulcerans disease.

Authors:  M R Evans; R Phillips; S N Etuaful; G Amofah; J Adomako; O Adjei; J Dennis-Antwi; S B Lucas; M H Wansbrough-Jones
Journal:  Trans R Soc Trop Med Hyg       Date:  2003 Mar-Apr       Impact factor: 2.184

8.  Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, Southern Benin, 1997-2001.

Authors:  Martine Debacker; Julia Aguiar; Christian Steunou; Claude Zinsou; Wayne M Meyers; Augustin Guédénon; Janet T Scott; Michèle Dramaix; Françoise Portaels
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

9.  Sensitivity of direct versus concentrated sputum smear microscopy in HIV-infected patients suspected of having pulmonary tuberculosis.

Authors:  Adithya Cattamanchi; David W Dowdy; J Lucian Davis; William Worodria; Samuel Yoo; Moses Joloba; John Matovu; Philip C Hopewell; Laurence Huang
Journal:  BMC Infect Dis       Date:  2009-05-06       Impact factor: 3.090

10.  Histopathologic features of Mycobacterium ulcerans infection.

Authors:  Jeannette Guarner; Jeanine Bartlett; Ellen A Spotts Whitney; Pratima L Raghunathan; Ymkje Stienstra; Kwame Asamoa; Samuel Etuaful; Erasmus Klutse; Eric Quarshie; Tjip S van der Werf; Winette T A van der Graaf; C Harold King; David A Ashford
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

View more
  16 in total

1.  Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study.

Authors:  Joseph Tuffour; Evelyn Owusu-Mireku; Marie-Therese Ruf; Samuel Aboagye; Grace Kpeli; Victor Akuoku; Janet Pereko; Albert Paintsil; Kofi Bonney; William Ampofo; Gerd Pluschke; Dorothy Yeboah-Manu
Journal:  Am J Trop Med Hyg       Date:  2015-06-08       Impact factor: 2.345

2.  Effects of decontamination, DNA extraction, and amplification procedures on the molecular diagnosis of Mycobacterium ulcerans disease (Buruli ulcer).

Authors:  Dissou Affolabi; N'Dira Sanoussi; Koen Vandelannoote; Mathieu Odoun; Frank Faïhun; Ghislain Sopoh; Séverin Anagonou; Françoise Portaels; Miriam Eddyani
Journal:  J Clin Microbiol       Date:  2012-01-18       Impact factor: 5.948

3.  Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin.

Authors:  Dorothy Yeboah-Manu; Grace S Kpeli; Marie-Thérèse Ruf; Kobina Asan-Ampah; Kwabena Quenin-Fosu; Evelyn Owusu-Mireku; Albert Paintsil; Isaac Lamptey; Benjamin Anku; Cynthia Kwakye-Maclean; Mercy Newman; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2013-05-02

4.  Identification of the Mycobacterium ulcerans protein MUL_3720 as a promising target for the development of a diagnostic test for Buruli ulcer.

Authors:  Anita Dreyer; Katharina Röltgen; Jean Pierre Dangy; Marie Thérèse Ruf; Nicole Scherr; Miriam Bolz; Nicholas Jay Tobias; Charles Moes; Andrea Vettiger; Timothy Paul Stinear; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2015-02-10

5.  Genotyping Tools for Mycobacterium ulcerans-Drawbacks and Future Prospects.

Authors:  Charles A Narh; Lydia Mosi; Charles Quaye; Samuel Ck Tay; Bassirou Bonfoh; Dziedzom K de Souza
Journal:  Mycobact Dis       Date:  2014-05-05

6.  A case of cutaneous tuberculosis in a Buruli ulcer-endemic area.

Authors:  Martin W Bratschi; Earnest Njih Tabah; Miriam Bolz; David Stucki; Sonia Borrell; Sebastien Gagneux; Blanbin Noumen-Djeunga; Thomas Junghanss; Alphonse Um Boock; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2012-08-28

7.  Implementation of a national reference laboratory for Buruli ulcer disease in Togo.

Authors:  Marcus Beissner; Kristina Lydia Huber; Kossi Badziklou; Wemboo Afiwa Halatoko; Issaka Maman; Felix Vogel; Bawimodom Bidjada; Koffi Somenou Awoussi; Ebekalisai Piten; Kerstin Helfrich; Carolin Mengele; Jörg Nitschke; Komi Amekuse; Franz Xaver Wiedemann; Adolf Diefenhardt; Basile Kobara; Karl-Heinz Herbinger; Abiba Banla Kere; Mireille Prince-David; Thomas Löscher; Gisela Bretzel
Journal:  PLoS Negl Trop Dis       Date:  2013-01-24

8.  Geographic distribution, age pattern and sites of lesions in a cohort of Buruli ulcer patients from the Mapé Basin of Cameroon.

Authors:  Martin W Bratschi; Miriam Bolz; Jacques C Minyem; Leticia Grize; Fidèle G Wantong; Sarah Kerber; Earnest Njih Tabah; Marie-Thérèse Ruf; Ferdinand Mou; Djeunga Noumen; Alphonse Um Boock; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2013-06-13

9.  Multicenter external quality assessment program for PCR detection of Mycobacterium ulcerans in clinical and environmental specimens.

Authors:  Miriam Eddyani; Caroline Lavender; Willem Bram de Rijk; Pieter Bomans; Janet Fyfe; Bouke de Jong; Françoise Portaels
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

10.  Genetic diversity of PCR-positive, culture-negative and culture-positive Mycobacterium ulcerans isolated from Buruli ulcer patients in Ghana.

Authors:  Heather Williamson; Richard Phillips; Stephen Sarfo; Mark Wansbrough-Jones; Pamela Small
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.